🇺🇸 FDA
Patent

US 8372843

Quinolines useful as modulators of ION channels

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8372843 (Quinolines useful as modulators of ION channels) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/12